RT Journal Article
SR Electronic
T1 Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007444
DO 10.1136/jitc-2023-007444
VO 11
IS 10
A1 Park, Junsik
A1 Lee, Jung Bok
A1 Lim, Myong Cheol
A1 Kim, Byoung-Gie
A1 Kim, Jae-Weon
A1 Kim, Sunghoon
A1 Choi, Chel Hun
A1 Kim, Hee Seung
A1 Park, Sang Yoon
A1 Lee, Jung-Yun
A1 
YR 2023
UL http://jitc.bmj.com/content/11/10/e007444.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.